PROCEPT BioRobotics

PROCEPT BioRobotics Corporation is a surgical robotics company based in Redwood Shores, California, that specializes in developing innovative solutions for urology. The company is known for its AquaBeam Robotic System, an advanced, image-guided surgical robot designed for minimally invasive procedures, particularly for treating benign prostatic hyperplasia (BPH). BPH affects approximately 40 million men in the United States and can lead to lower urinary tract symptoms (LUTS). PROCEPT's Aquablation therapy aims to provide effective and durable treatment outcomes that are not influenced by prostate size or the surgeon's experience. The company has established a robust body of clinical evidence, including nine clinical studies and over 100 peer-reviewed publications, demonstrating the clinical advantages of its Aquablation therapy. Revenue is primarily generated through the sales of the AquaBeam Robotic System and its disposable handpieces.